Overview
- The Aurora manufacturing campus held a ribbon-cutting and began operations Monday as Philip Morris announced it had doubled its planned investment to about $1.2 billion through 2028 to expand ZYN nicotine pouch output.
- Company officials say the 780,000-square-foot campus will create about 500 direct jobs, support roughly 1,000 indirect jobs, and generate an estimated $550 million in annual economic impact once fully operational.
- The boost follows the FDA’s recent authorization that allows Philip Morris to market 20 ZYN products as less harmful than cigarettes, a change the company says supports its pivot from combustible tobacco to smoke-free products.
- Local health advocates voiced sharp concerns about youth exposure and heavy industry advertising spending while noting local policy steps such as Denver’s flavored-tobacco sales ban to limit appeal to children.
- ZYN is the market leader in the fast-growing U.S. nicotine-pouch category and the Aurora plant is meant to strengthen supply, produce newer higher-nicotine formats like ZYN Ultra, and serve export markets in Asia, Latin America and the Caribbean.